360 related articles for article (PubMed ID: 30898132)
1. Surgical resection of the primary tumor leads to prolonged survival in metastatic pancreatic neuroendocrine carcinoma.
Feng T; Lv W; Yuan M; Shi Z; Zhong H; Ling S
World J Surg Oncol; 2019 Mar; 17(1):54. PubMed ID: 30898132
[TBL] [Abstract][Full Text] [Related]
2. Primary tumor resection enhances the survival of pancreatic neuroendocrine carcinoma patients with liver metastasis under the definition of 2019 WHO classification.
Luo W; Zhang T
J Cancer Res Clin Oncol; 2023 Sep; 149(11):9201-9212. PubMed ID: 37184680
[TBL] [Abstract][Full Text] [Related]
3. Surgical resection of high-grade nonfunctional pancreatic neuroendocrine carcinoma is associated with improved survival.
Jiang J; Park J; Kim S; Daan A; Donahue T; Girgis MD
J Surg Oncol; 2021 Dec; 124(8):1373-1380. PubMed ID: 34406651
[TBL] [Abstract][Full Text] [Related]
4. Palliative Resection of Primary Tumor in Metastatic Nonfunctioning Pancreatic Neuroendocrine Tumors.
Ye H; Xu HL; Shen Q; Zheng Q; Chen P
J Surg Res; 2019 Nov; 243():578-587. PubMed ID: 31031022
[TBL] [Abstract][Full Text] [Related]
5. Non-functional neuroendocrine carcinoma of the pancreas: incidence, tumor biology, and outcomes in 2,158 patients.
Franko J; Feng W; Yip L; Genovese E; Moser AJ
J Gastrointest Surg; 2010 Mar; 14(3):541-8. PubMed ID: 19997980
[TBL] [Abstract][Full Text] [Related]
6. Prognosis analysis of patients with pancreatic neuroendocrine tumors after surgical resection and the application of enucleation.
Chen J; Yang Y; Liu Y; Kan H
World J Surg Oncol; 2021 Jan; 19(1):11. PubMed ID: 33436017
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Tumor Location on Resection and Survival for Pancreatic Ductal Adenocarcinoma.
Winer LK; Dhar VK; Wima K; Morris MC; Lee TC; Shah SA; Ahmad SA; Patel SH
J Surg Res; 2019 Jul; 239():60-66. PubMed ID: 30802706
[TBL] [Abstract][Full Text] [Related]
8. Surgery for Pancreatic Neuroendocrine Tumor G3 and Carcinoma G3 Should be Considered Separately.
Yoshida T; Hijioka S; Hosoda W; Ueno M; Furukawa M; Kobayashi N; Ikeda M; Ito T; Kodama Y; Morizane C; Notohara K; Taguchi H; Kitano M; Yane K; Tsuchiya Y; Komoto I; Tanaka H; Tsuji A; Hashigo S; Mine T; Kanno A; Murohisa G; Miyabe K; Takagi T; Matayoshi N; Sakaguchi M; Ishii H; Kojima Y; Matsuo K; Yoshitomi H; Nakamori S; Yanagimoto H; Yatabe Y; Furuse J; Mizuno N
Ann Surg Oncol; 2019 May; 26(5):1385-1393. PubMed ID: 30863939
[TBL] [Abstract][Full Text] [Related]
9. Palliative resection of the primary tumor in 442 metastasized neuroendocrine tumors of the pancreas: a population-based, propensity score-matched survival analysis.
Hüttner FJ; Schneider L; Tarantino I; Warschkow R; Schmied BM; Hackert T; Diener MK; Büchler MW; Ulrich A
Langenbecks Arch Surg; 2015 Aug; 400(6):715-23. PubMed ID: 26198970
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes and prognostic factors in neuroendocrine carcinomas of the pancreas: Morphology matters.
Crippa S; Partelli S; Bassi C; Berardi R; Capelli P; Scarpa A; Zamboni G; Falconi M
Surgery; 2016 Mar; 159(3):862-71. PubMed ID: 26602841
[TBL] [Abstract][Full Text] [Related]
11. Operative resection in early stage pancreatic neuroendocrine tumors in the United States: Are we over- or undertreating patients?
Chivukula SV; Tierney JF; Hertl M; Poirier J; Keutgen XM
Surgery; 2020 Jan; 167(1):180-186. PubMed ID: 31537303
[TBL] [Abstract][Full Text] [Related]
12. [Surgical treatment and prognosis of pancreatic neuroendocrine carcinoma].
Zhang JW; Che X; Lan ZM; Chen YT; Huang XH; Jiang QL; Wang CF
Zhonghua Zhong Liu Za Zhi; 2016 Dec; 38(12):925-928. PubMed ID: 27998470
[No Abstract] [Full Text] [Related]
13. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
[TBL] [Abstract][Full Text] [Related]
14. Surgical Treatment as a Principle for Patients with High-Grade Pancreatic Neuroendocrine Carcinoma: A Nordic Multicenter Comparative Study.
Haugvik SP; Janson ET; Österlund P; Langer SW; Falk RS; Labori KJ; Vestermark LW; Grønbæk H; Gladhaug IP; Sorbye H
Ann Surg Oncol; 2016 May; 23(5):1721-8. PubMed ID: 26678407
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological Characteristics and Survival Outcomes of Primary Hepatic Neuroendocrine Tumor: A Surveillance, Epidemiology, and End Results (SEER) Population-Based Study.
Li YF; Zhang QQ; Wang WL
Med Sci Monit; 2020 Jul; 26():e923375. PubMed ID: 32651994
[TBL] [Abstract][Full Text] [Related]
16. Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis.
Zheng M; Li Y; Li T; Zhang L; Zhou L
Cancer Med; 2019 Sep; 8(11):5128-5136. PubMed ID: 31328428
[TBL] [Abstract][Full Text] [Related]
17. Impact of different surgical procedures on survival outcomes of patients with adenocarcinoma of pancreatic neck.
Zheng Z; Tan C; Chen Y; Ping J; Wang M
PLoS One; 2019; 14(5):e0217427. PubMed ID: 31125386
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological features and prognosis factors for survival in elderly patients with pancreatic neuroendocrine tumor: A STROBE-compliant article.
Li G; Tian ML; Bing YT; Tao LY; Wang HY; Jiang B; Yuan CH; Xiu DR
Medicine (Baltimore); 2019 Mar; 98(11):e14576. PubMed ID: 30882623
[TBL] [Abstract][Full Text] [Related]
19. Overall survival in patients over 40 years old with surgically resected pancreatic carcinoma: a SEER-based nomogram analysis.
Li J; Liu L
BMC Cancer; 2019 Jul; 19(1):726. PubMed ID: 31337369
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of chemotherapy and operation in patients with colorectal neuroendocrine carcinoma.
Wu Z; Yu D; Zhao S; Gao P; Song Y; Sun Y; Chen X; Wang Z
J Surg Res; 2018 May; 225():54-67. PubMed ID: 29605035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
